| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.19 | 0.0001 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0008 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.0008 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.094 | 0.001 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.004 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.004 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.004 |